{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:59:34Z","timestamp":1785394774886,"version":"3.55.0"},"reference-count":109,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use: Research and Treatment"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Disproportionately high mortality rates from opioid overdose among adolescents have emerged as a major public health concern in the United States (U.S.). Among available interventions, naloxone, an opioid receptor antagonist, continues to be recognized for its effectiveness in reversing opioid overdose. However, access to naloxone among adolescents remains scarce, underscoring potential gaps in overdose prevention for this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This narrative review examines current literature to identify barriers and facilitators that influence naloxone availability and uptake among adolescents. The review includes young adult (up to age 30) data when it overlaps with adolescent literature. The review followed the SANRA checklist criteria and utilized the Cochrane, MEDLINE-PubMed, and Google Scholar databases for relevant studies from 2012-2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Findings<\/jats:title>\n                    <jats:p>Barriers to naloxone access are multifactorial, including cost-related constraints, inconsistent implementation of over-the-counter dispensing practices, limited awareness of dispensing policies, and stigma towards people who use drugs. Structural and individual factors found to assist in the facilitation of naloxone access include policy changes enabling non-prescription dispensing, pharmacy standing orders, and laws that permit independent minor consent for substance use treatment. However, disparities in naloxone availability and use persist, and implementation of such policies is inconsistent across settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recommendations<\/jats:title>\n                    <jats:p>Accordingly, legislation that promotes naloxone availability and educational initiatives designed to increase knowledge and acceptance of its use in diverse settings may be important, as evidence supports its association with reduced overdose mortality. Additional efforts are warranted to improve naloxone availability and use among adolescents, including expansion of clinician prescribing practices, reduction of costs at the point-of-dispense, and greater distribution of the medication for patients leaving treatment facilities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/29768357261472425","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:26:37Z","timestamp":1785183997000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers and Facilitators to Naloxone Access for Adolescents: A Narrative Review"],"prefix":"10.1177","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5717-7109","authenticated-orcid":false,"given":"Cristian R.","family":"Ramos","sequence":"first","affiliation":[{"name":"Emory University Rollins School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2418-8987","authenticated-orcid":false,"given":"Kathleen H.","family":"Krause","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica M.","family":"Joseph","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darja","family":"Beinenson","sequence":"additional","affiliation":[{"name":"Behavioral and Mental Health, Children\u2019s Healthcare of Atlanta, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha C.","family":"Patton","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1641-4253","authenticated-orcid":false,"given":"Katharine","family":"Torrey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1926-4003","authenticated-orcid":false,"given":"Mansi","family":"Chaubey","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Mathias","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet R.","family":"Cummings","sequence":"additional","affiliation":[{"name":"Emory University Rollins School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-744X","authenticated-orcid":false,"given":"Justine W.","family":"Welsh","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.5035"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/19427891251401921"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.2847"},{"key":"e_1_3_5_5_2","volume-title":"Fentanyl","author":"National Institute on Drug Abuse (NIDA)","year":"2021","unstructured":"National Institute on Drug Abuse (NIDA). Fentanyl; 2021. https:\/\/nida.nih.gov\/research-topics\/fentanyl. Accessed February 15, 2026."},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104417"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2312084"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069488"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6558"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7150a2"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22210-8"},{"key":"e_1_3_5_12_2","volume-title":"Naloxone DrugFacts","author":"National Institute on Drug Abuse (NIDA)","year":"2022","unstructured":"National Institute on Drug Abuse (NIDA). Naloxone DrugFacts; 2022. https:\/\/nida.nih.gov\/publications\/drugfacts\/naloxone. Accessed February 22, 2026."},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.6.2.125"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/02724316241277963"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.103980"},{"key":"e_1_3_5_16_2","article-title":"State Unintentional Drug Overdose Reporting System (SUDORS)","author":"U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC)","year":"2026","unstructured":"U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). State Unintentional Drug Overdose Reporting System (SUDORS). Final Data. 2026. https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/sudors-dashboard-fatal-overdose-data.html. Accessed February 22, 2026.","journal-title":"Final Data"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40124-018-0161-z"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2056C"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306306"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-021-00309-z"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-067258"},{"key":"e_1_3_5_22_2","unstructured":"American Academy of Pediatrics (AAP). Resources to Address the Opioid Epidemic. 2025. https:\/\/www.aap.org\/en\/patient-care\/substance-use-and-prevention\/resources-to-address-the-opioid-epidemic\/. Accessed February 15 2026."},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000633"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-065137"},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","unstructured":"U.S. Food & Drug Administration (FDA). FDA Approves First Over-the-Counter Naloxone Nasal Spray. 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-over-counter-naloxone-nasal-spray. Accessed February 15 2026.","DOI":"10.47287\/cen-10124-buscon16"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.5863\/JPPT-25-00020"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.62414\/001c.158236"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00599-4"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-197807000-00001"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108584"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.2143"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.35416"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000898"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.0745"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2025.6113"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001501"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/amajethics.2024.534"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.01.030"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.1920"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2025.209762"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.2663"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.12866"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2025.102357"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000492"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.06.001"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2019.07.009"},{"key":"e_1_3_5_48_2","volume-title":"Pharmacists Slow To Dispense Lifesaving Overdose Drug","author":"Gorman A","year":"2018","unstructured":"Gorman A. Pharmacists Slow To Dispense Lifesaving Overdose Drug. KFF Health News; 2018. https:\/\/kffhealthnews.org\/news\/pharmacists-slow-to-dispense-lifesaving-overdose-drug\/. Accessed February 23, 2026."},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800427"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2018.05.011"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40596-018-0959-6"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-023-01257-x"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedn.2019.10.005"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2024.0561"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100265"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-26.2.133"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2023.08.040"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2025.2522150"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2025-073766"},{"key":"e_1_3_5_60_2","unstructured":"Ramos C Clemans-Cope L Samuel-Jakubos H Basurto LE. Evidence-Based Interventions for Adolescent Opioid Use Disorder: What Might Work for High-Risk Ohio Counties? 2018. https:\/\/www.urban.org\/research\/publication\/evidence-based-interventions-adolescent-opioid-use-disorder. Accessed March 23 2026."},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.3390\/children12070876"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000272"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.2196\/22411"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.09.008"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.0272"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15163"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.27236"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2024.3701"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1893"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069298"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112677"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000958"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112814"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1177\/15248399251318695"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2024.03.010"},{"key":"e_1_3_5_76_2","unstructured":"U.S. Food & Drug Administration (FDA). FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. 2020. Published online. https:\/\/www.fda.gov\/drugs\/drug-safety-communications\/fda-recommends-health-care-professionals-discuss-naloxone-all-patients-when-prescribing-opioid-pain. Accessed May 22 2026."},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2021.09.005"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000348"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2012.703510"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S304566"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.20469"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1086\/700703"},{"key":"e_1_3_5_83_2","unstructured":"Legislative Analysis and Public Policy Association. Naloxone: Summary of State Laws. 2022. https:\/\/legislativeanalysis.org\/wp-content\/uploads\/2022\/09\/Naloxone-Access-Summary-of-State-Laws.pdf. Accessed March 23 2026."},{"key":"e_1_3_5_84_2","unstructured":"The Network for Public Health Law. Opioid misuse and overdose prevention: 50-state survey. 2020. https:\/\/www.networkforphl.org\/wp-content\/uploads\/2021\/02\/50-State-Survey-Legal-Interventions-to-Reduce-Overdose-Mortality-Naloxone-Access-Laws.pdf. Accessed May 17 2026."},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.5863\/JPPT-25-00157"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-025-01473-7"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2025.108268"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.1080\/07448481.2020.1807992"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2014.989352"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13741-5"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-023523D"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2024.2443938"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.1080\/07448481.2023.2299404"},{"key":"e_1_3_5_94_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2019.0013"},{"key":"e_1_3_5_95_2","volume-title":"State Policy Approaches to Expand Naloxone Access","author":"Duncan A","year":"2025","unstructured":"Duncan A, Izquierdo B, McBournie A, McGaffey F. State Policy Approaches to Expand Naloxone Access; 2025. https:\/\/pewtrsts.org\/4fNQKKZ. Accessed March 25, 2026."},{"key":"e_1_3_5_96_2","volume-title":"Naloxone","author":"Georgia Department of Public Health (DPH)","year":"2024","unstructured":"Georgia Department of Public Health (DPH). Naloxone; 2024. https:\/\/dph.georgia.gov\/stopopioidaddiction\/what-you-need-know-about-opioids\/naloxone. Accessed March 16, 2026."},{"key":"e_1_3_5_97_2","author":"O\u2019Neill Institute Center for Addiction & Public Policy","year":"2024","unstructured":"O\u2019Neill Institute Center for Addiction & Public Policy. State Legislative Round-Up. 2024. https:\/\/oneill.law.georgetown.edu\/wp-content\/uploads\/2024\/08\/2024-APP-Legislative-Roundup-QuickTake-8.5x11.pdf","journal-title":"State Legislative Round-Up"},{"key":"e_1_3_5_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.03.014"},{"key":"e_1_3_5_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104462"},{"key":"e_1_3_5_100_2","doi-asserted-by":"publisher","unstructured":"Rebola CB Ramirez Loaiza S. AntiOD: A Smart City Initiative to Fight the Opioid Crisis. In: Arai K Bhatia R Kapoor S eds. Proceedings of the Future Technologies Conference (FTC) 2019. Springer International Publishing; 2020:300-305. doi:10.1007\/978-3-030-32520-6_24.","DOI":"10.1007\/978-3-030-32520-6_24"},{"key":"e_1_3_5_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109323"},{"key":"e_1_3_5_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.08.003"},{"key":"e_1_3_5_103_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2024.307849"},{"key":"e_1_3_5_104_2","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2025-008620"},{"key":"e_1_3_5_105_2","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2015.2.24909"},{"key":"e_1_3_5_106_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2025.5714"},{"key":"e_1_3_5_107_2","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.47387"},{"key":"e_1_3_5_108_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40596-025-02176-w"},{"key":"e_1_3_5_109_2","volume-title":"Community Management of Opioid Overdose","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO). Community Management of Opioid Overdose; 2014. https:\/\/www.who.int\/publications\/i\/item\/9789241548816. Accessed March 16, 2026."},{"key":"e_1_3_5_110_2","volume-title":"Lifesaving Naloxone","author":"Centers for Disease Control and Prevention (CDC)","year":"2025","unstructured":"Centers for Disease Control and Prevention (CDC). Lifesaving Naloxone; 2025. https:\/\/www.cdc.gov\/stop-overdose\/caring\/naloxone.html. Accessed March 16, 2026."}],"container-title":["Substance Use: Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768357261472425","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29768357261472425","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768357261472425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:16:42Z","timestamp":1785392202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29768357261472425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":109,"alternative-id":["10.1177\/29768357261472425"],"URL":"https:\/\/doi.org\/10.1177\/29768357261472425","relation":{},"ISSN":["2976-8357","2976-8357"],"issn-type":[{"value":"2976-8357","type":"print"},{"value":"2976-8357","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"29768357261472425"}}